# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123239
Filing Date
2024-11-07
Accepted
2024-11-07 16:00:28
Documents
68
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vera-20240930.htm iXBRL | 10-Q | 2331289
2 | EX-10.2 | vera-ex10_2.htm | EX-10.2 | 331804
3 | EX-31.1 | vera-ex31_1.htm | EX-31.1 | 15983
4 | EX-31.2 | vera-ex31_2.htm | EX-31.2 | 15952
5 | EX-32.1 | vera-ex32_1.htm | EX-32.1 | 9449
6 | EX-32.2 | vera-ex32_2.htm | EX-32.2 | 9651
| Complete submission text file | 0000950170-24-123239.txt |  | 8367865

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | vera-20240930.xsd | EX-101.SCH | 1096652
71 | EXTRACTED XBRL INSTANCE DOCUMENT | vera-20240930_htm.xml | XML | 1238933

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 241435341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)